Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 26

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 26
---
 auditing or related matters pertaining to the Company may be submitted by our employees confidentially and anonymously by contacting the Company’s Integrity Hotline. The Integrity Hotline is an independent third party that the Company has retained to receive anonymous complaints from the Company’s employees.

| Prestige Consumer Healthcare Inc. | 2025 Proxy Statement |     | 35 |

DIRECTOR COMPENSATION

Overview The Compensation and Talent Management Committee retains Compensation Advisory Partners LLC (“CAP”) to perform a full review of director compensation against the Company’s peer group every other year. CAP most recently performed a full review against the peer group in August 2023 . In consideration of the advice and recommendations from CAP, the Compensation and Talent Management Committee recommended, and the Board approved, the compensation program for directors which became effective as of August 1, 2023. CAP is expected to complete a full review of director compensation against the Company’s peer group in August 2025. Elements of Director Compensation Under the director compensation program, each of our directors other than Mr. Lombardi receives the following cash and equity compensation for their services as a director:

| Position                                                  | 2025 AdditionalAnnual Fee($) |
| Chair of the Audit and Finance Committee                  |                       20,000 |
| Chair of the Compensation and TalentManagement Committee  |                       20,000 |
| Chair of the Nominating and CorporateGovernance Committee |                       15,000 |
| Lead Independent Director                                 |                       30,000 |

• The annual grant of restricted stock units valued at $150,000 are awarded on the date of the election of each director at the annual meeting of stockholders, which restricted stock units vest one year after the date of grant so long as membership on the Board of Directors continues through the vesting date. Settlement in common stock occurs at each recipient’s prior election, either upon vesting or on the earliest of the director’s death, disability or the date on which the director’s board membership ceases for reasons other than death or disability; • If a director is elected at a time other than the annual meeting, they receive a pro-rated grant of restricted stock units for service provided between the date he or she first becomes a director and the next annual meeting of stockholders. • The $95,000 annual cash retainer fee is paid in equal quarterly installments, reflecting a $5,000 increase from fiscal 2023. • No meeting fees are payable to directors. • Our directors are reimbursed for out-of-pocket expenses incurred in connection with Board